NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Therapeutic Stories

GuidelineTherapeutic Poo Transplants to Fight Superbugs – NICE adopt guidelines spearheaded by NIHR Imperial BRC Researchers

GuidelineTherapeutic Poo Transplants to Fight Superbugs – NICE adopt guidelines spearheaded by NIHR Imperial BRC Researchers

Published on 2nd September 2022
InnovationTherapeutic Changing the order of breast cancer treatments may lead to better care

InnovationTherapeutic Changing the order of breast cancer treatments may lead to better care

Published on 3rd August 2022
PartnershipTherapeutic Pausing immune-supressing treatment can improve the efficiency of the COVID-19 booster

PartnershipTherapeutic Pausing immune-supressing treatment can improve the efficiency of the COVID-19 booster

Published on 16th July 2022
InnovationTherapeutic First patient randomised into super donor plasma trial at Charing Cross hospital

InnovationTherapeutic First patient randomised into super donor plasma trial at Charing Cross hospital

Published on 30th June 2022
InnovationTherapeutic Kisspeptin hormone can enhance human bone activity

InnovationTherapeutic Kisspeptin hormone can enhance human bone activity

Published on 11th April 2022
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Treatment Flexible hepatitis C treatments could pave the way for elimination
  • Training NIHR Imperial BRC pre-application support funds
  • Prevention Progesterone-only contraceptive pill linked to increased asthma risk in some women
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre